Europe Allergic Rhinitis Epidemiology and Patient Flow Analysis - 2017

Europe Allergic Rhinitis Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Allergic Rhinitis patients study in a new report ‘Europe Allergic Rhinitis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Allergic Rhinitis epidemiology, Allergic Rhinitis diagnosed patients, and Allergic Rhinitis treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Allergic Rhinitis derived from epidemiological analysis, percentage of patients diagnosed with Allergic Rhinitis, and percentage of patients treated with a therapy.

The study helps executives estimate Allergic Rhinitis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Allergic Rhinitis prevalence, Allergic Rhinitis diagnosis rate, and Allergic Rhinitis treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

• Allergic Rhinitis Patient Flow
• Allergic Rhinitis Prevalence
• Allergic Rhinitis Diagnosed Patients
• Allergic Rhinitis Treated Patients